FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Markus Reindl

Research Profile

Disorders

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Lindsay A Hohsfield; Stephan Geley; Markus Reindl; Christian Humpel
The generation of NGF-secreting primary rat monocytes: A comparison of different transfer methods.
Viktoria Gredler; Harald Hegen; Bettina Kuenz; Thomas Berger; Florian Deisenhammer; Franziska Di Pauli; Simone Mader; Markus Reindl; Kathrin Schanda; Andreas Lutterotti
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
Lisa Fellner; Regina Irschick; Lars Klimaschewski; Werner Poewe; Markus Reindl; Kathrin Schanda; Gregor Wenning; Nadia Stefanova
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Markus Reindl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lindsay A Hohsfield; Stephan Geley; Markus Reindl; Christian Humpel
The generation of NGF-secreting primary rat monocytes: A comparison of different transfer methods.
Journal of immunological methods 2013;391(1-2):112-24.
2013: Viktoria Gredler; Harald Hegen; Bettina Kuenz; Thomas Berger; Florian Deisenhammer; Franziska Di Pauli; Simone Mader; Markus Reindl; Kathrin Schanda; Andreas Lutterotti
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
Journal of the neurological sciences 2013;328(1-2):77-82.
2013: Lisa Fellner; Regina Irschick; Lars Klimaschewski; Werner Poewe; Markus Reindl; Kathrin Schanda; Gregor Wenning; Nadia Stefanova
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.
Glia 2013;61(3):349-60.
2013: Daniela Besong-Agbo; Michael Bacher; Eva Hametner; Frank Jessen; Carmen Noelker; Matthias Oechsner; Wolfgang H Oertel; Werner Poewe; Markus Reindl; Elias Wolf; Richard Dodel
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.
Neurology 2013;80(2):169-75.
2012: Marlene Fischer; Raimund Helbok; Peter Lackner; Bettina Pfausler; Markus Reindl; Erich Schmutzhard; Ronny Beer; Anelia Dietmann; Gregor Broessner
Endovascular cooling and endothelial activation in hemorrhagic stroke patients.
Neurocritical care 2012;17(2):224-30.
2012: Wolfgang Nachbauer; Werner Poewe; Markus Reindl; Sylvia Boesch; Andreas Eigentler; Kurt Hufler; Wolfgang Löscher; Julia Wanschitz
Skeletal muscle involvement in friedreich ataxia and potential effects of recombinant human erythropoietin administration on muscle regeneration and neovascularization.
Journal of neuropathology and experimental neurology 2012;71(8):708-15.
2012: Kevin Rostasy; Kathrin Schanda; Mareike Schimmel; Daniel Tibussek; Barbara Bajer-Kornek; Thomas Berger; Astrid Blaschek; Franziska Di Pauli; Jutta Gärtner; Peter Huppke; Michael Karenfort; Verena Kraus; Steffen Leitz; Simone Mader; Markus Reindl
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.
Archives of neurology 2012;69(6):752-6.
2012: Mascha C Schmied; Karl Vass; H-Erich Wichmann; Karin Zebenholzer; Sonja Zehetmayer; Eduard Auff; Barbara Bajer-Kornek; Thomas Berger; Rainer Ehling; Franz Fazekas; Sigrid Fuchs; Christian Gieger; Christoph Hotzy; Klaus Huber; Thomas Illig; Michael Khalil; W Kristoferitsch; Fritz Leutmezer; Peter Lichtner; Thomas Meitinger; Markus Reindl; Helena Schmidt; Alexander Zimprich
Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients.
Neurogenetics 2012;13(2):181-7.
2012: Philipp Mahlknecht; Werner Poewe; Johannes Rainer; Christoph Scherfler; Klaus Seppi; Fabienne Sprenger; Sylvia Stemberger; Gregor Wenning; Christoph Grabmer; Eva Hametner; Rudolf Kirchmair; Markus Reindl
An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes.
Proteome science 2012;10(1):71.
2011: Wolfgang Nachbauer; Werner Poewe; Markus Reindl; Barbara Scheiber-Mojdehkar; Markus Seifert; Hannes Steinkellner; Alexander Strasak; Brigitte Sturm; Guenter Weiss; Sascha Hering; Sylvia Boesch
Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial.
Cerebellum (London, England) 2011;10(4):763-9.
2011: Andreas Lutterotti; Markus Reindl; M Vedovello; Florian Deisenhammer; F DiPauli; Rainer Ehling; Claudia Gneiss; Bettina Kuenz; Thomas Berger
Olfactory threshold is impaired in early, active multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(8):964-9.
2011: Maria Pohl; Markus Reindl; Kathrin Schanda; Rakhi Sharma; Isabella Wimmer; Marie-Therese Fischer; Kazuo Fujihara; Maja Kitic; Hans Lassmann; Simone Mader; Tatsuro Misu; Monika Bradl
Pathogenic T cell responses against aquaporin 4.
Acta neuropathologica 2011;122(1):21-34.
2011: Irena Dujmovic; Simone Mader; Kathrin Schanda; Florian Deisenhammer; Nebojsa Stojsavljevic; Jelena Kostic; Thomas Berger; Jelena Drulovic; Markus Reindl
Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders.
Journal of neuroimmunology 2011;234(1-2):124-30.
2011: Franziska Di Pauli; Simone Mader; Kevin Rostasy; Kathrin Schanda; Barbara Bajer-Kornek; Rainer Ehling; Florian Deisenhammer; Markus Reindl; Thomas Berger
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
Clinical immunology (Orlando, Fla.) 2011;138(3):247-54.
2011: Simone Mader; Kristian Pfaller; Kevin Rostasy; Kathrin Schanda; Maria K Storch; Fahmy Aboul-Enein; Thomas Berger; Florian Deisenhammer; Franziska Di Pauli; Jelena Drulovic; Irena Dujmovic; Rainer Ehling; Viktoria Gredler; Harald Hegen; Sven Jarius; Peter Koson; W Kristoferitsch; Bettina Kuenz; Andreas Lutterotti; Markus Reindl
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Journal of neuroinflammation 2011;8():184.
2011: Karin Steinbach; Christine E Bandtlow; Claire L McDonald; Markus Reindl; Rüdiger Schweigreiter; Roland Martin
Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis.
PloS one 2011;6(11):e26341.
2011: Rainer Ehling; Claudia Gneiss; Harald Hegen; Bettina Kuenz; Peter Lackner; Andreas Lutterotti; Franziska Di Pauli; Thomas Berger; Florian Deisenhammer; Wolfram Santner; Michael Schocke; Markus Reindl
Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis.
Fluids and barriers of the CNS 2011;8(1):25.
2011: Claire L McDonald; Christine E Bandtlow; Florian Kern; Roland Martin; Rüdiger Schweigreiter; Karin Steinbach; Markus Reindl
Nogo receptor is involved in the adhesion of dendritic cells to myelin.
Journal of neuroinflammation 2011;8():113.
2011: Sylvia Stemberger; Angelika Jamnig; Nadia Stefanova; Günter Lepperdinger; Markus Reindl; Gregor K Wenning
Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection.
PloS one 2011;6(5):e19808.
2011: Kathrin Schanda; Martin Hermann; Nadia Stefanova; Viktoria Gredler; Christine Bandtlow; Markus Reindl
Nogo-B is associated with cytoskeletal structures in human monocyte-derived macrophages.
BMC research notes 2011;4():6.
2011: C L McDonald; Christine E Bandtlow; Markus Reindl
Targeting the Nogo receptor complex in diseases of the central nervous system.
Current medicinal chemistry 2011;18(2):234-44.
2010: alban millonig; Harald Hegen; Franziska Di Pauli; Rainer Ehling; Claudia Gneiss; Martina Hoelzl; Bettina Künz; Andreas Lutterotti; Dagmar Rudzki; Thomas Berger; Markus Reindl; Florian Deisenhammer
Natalizumab treatment reduces endothelial activity in MS patients.
Journal of neuroimmunology 2010;227(1-2):190-4.
2010: Peter Willeit; Johann Willeit; Anita Brandstätter; Silvia Ehrlenbach; Agnes Mayr; Arno Gasperi; Siegfried Weger; Friedrich Oberhollenzer; Markus Reindl; Florian Kronenberg; Stefan Kiechl
Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(8):1649-56.
2010: T De Zordo; R Chhem; Vinzenz Smekal; Gudrun Feuchtner; Markus Reindl; Christian Fink; R Faschingbauer; Werner Jaschke; Andrea Klauser
Real-time sonoelastography: findings in patients with symptomatic achilles tendons and comparison to healthy volunteers.
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2010;31(4):394-400.
2010: Harald Hegen; Julia Wanschitz; Rainer Ehling; Florian Deisenhammer; Wolfgang N Löscher; Markus Reindl; Thomas Berger
Anti-alpha B-crystallin immunoreactivity in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Journal of the peripheral nervous system : JPNS 2010;15(2):150-2.
2010: Rainer Ehling; Thomas Berger; Markus Reindl
Multiple sclerosis - established and novel therapeutic approaches.
Central nervous system agents in medicinal chemistry 2010;10(1):3-15.
2010: C Grabmer; W Nachbauer; K Schanda; P Feurle; K Loacker; E Scholz; Harald Schennach; Thomas Berger; Markus Reindl; Christoph Gassner
Fine mapping of T-cell immunoglobulin mucin domain gene 1 failed to detect a significant association with multiple sclerosis.
Tissue antigens 2010;75(3):235-41.
2010: Viktoria Gredler; Susanne Ebner; Kathrin Schanda; Markus Forstner; Thomas Berger; Nikolaus Romani; Markus Reindl
Impact of human myelin on the maturation and function of human monocyte-derived dendritic cells.
Clinical immunology (Orlando, Fla.) 2010;134(3):296-304.
2010: Silvia Ehrlenbach; Peter Willeit; Stefan Kiechl; Johann Willeit; Markus Reindl; Kathrin Schanda; Florian Kronenberg; Anita Brandstätter
Raising the bar on telomere epidemiology.
International journal of epidemiology 2010;39(1):308-9.
2010: Franziska Di Pauli; Viktoria Gredler; Bettina Kuenz; Andreas Lutterotti; Rainer Ehling; Claudia Gneiss; Michael Schocke; Florian Deisenhammer; Markus Reindl; Thomas Berger
Features of intrathecal immunoglobulins in patients with multiple sclerosis.
Journal of the neurological sciences 2010;288(1-2):147-50.
2010: Peter Lackner; Bettina Kuenz; Markus Reindl; Maria Morandell; Thomas Berger; Erich Schmutzhard; Christian Eggers
Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study.
Journal of neuroinflammation 2010;7():79.
2010: Joachim Schmutzhard; Christian H Kositz; Peter Lackner; Anelia Dietmann; Marlene Fischer; Rudolf Glueckert; Markus Reindl; Kurt Stephan; Herbert Riechelmann; Annelies Schrott-Fischer; Erich Schmutzhard
Murine malaria is associated with significant hearing impairment.
Malaria journal 2010;9():159.
2010: Simone Mader; Andreas Lutterotti; Franziska Di Pauli; Bettina Kuenz; Kathrin Schanda; Fahmy Aboul-Enein; Michael Khalil; Maria K Storch; Sven Jarius; Wolfgang Kristoferitsch; Thomas Berger; Markus Reindl
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
PloS one 2010;5(5):e10455.
2010: Markus Reindl; Bettina Kuenz; Thomas Berger
B cells and antibodies in MS.
Results and problems in cell differentiation 2010;51():99-113.
2009: Anelia Dietmann; Raimund Helbok; Peter Lackner; Marlene Fischer; Markus Reindl; Bertrand Lell; Saadou Issifou; Song Le; Erich Schmutzhard
Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis?
The Journal of infectious diseases 2009;200(12):1842-8.
2009: Claudia Gneiss; Pia-Maria Koudouovoh-Tripp; Stefan Ropele; Thaddäus Gotwald; Rainer Ehling; Andreas Lutterotti; Franz Aichner; Gunther Ladurner; Christian Eggers; Franz Schautzer; Bettina Künz; alban millonig; Engelbert Aspeck; Markus Reindl; Thomas Berger; Franz Fazekas; Florian Deisenhammer
Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(12):1481-8.
2009: Silvia Ehrlenbach; Peter Willeit; Stefan Kiechl; Johann Willeit; Markus Reindl; Kathrin Schanda; Florian Kronenberg; Anita Brandstätter
Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay.
International journal of epidemiology 2009;38(6):1725-34.
2009: Tobias De Zordo; Christian Fink; Gudrun Feuchtner; Vinzenz Smekal; Markus Reindl; Andrea Klauser
Real-time sonoelastography findings in healthy Achilles tendons.
AJR. American journal of roentgenology 2009;193(2):W134-8.
2009: alban millonig; D Rudzki; M Hölzl; Rainer Ehling; Claudia Gneiss; B Künz; Thomas Berger; Markus Reindl; Florian Deisenhammer
High-dose intravenous interferon beta in patients with neutralizing antibodies (HINABS): a pilot study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(8):977-83.
2009: Martin Köllensperger; Nadia Stefanova; Anton Pallua; Zoe Puschban; Georg Dechant; Monika Hainzer; Markus Reindl; Werner Poewe; Guido Nikkhah; Gregor Wenning
Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa response.
Journal of neuroscience research 2009;87(7):1679-85.
2009: F Di Pauli; Thomas Berger; Markus Reindl
Monoclonal antibodies in the treatment of multiple sclerosis.
Current medicinal chemistry 2009;16(36):4858-68.
2009: Peter Lackner; Andrea Part; Christoph Burger; Anelia Dietmann; Gregor Broessner; Raimund Helbok; Markus Reindl; Erich Schmutzhard; Ronny Beer
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
Malaria journal 2009;8():36.
2008: F Di Pauli; Markus Reindl; Rainer Ehling; F Schautzer; Claudia Gneiss; Andreas Lutterotti; Ej O'Reilly; Kl Munger; Florian Deisenhammer; A Ascherio; Thomas Berger
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(8):1026-30.
2008: Claudia Gneiss; M Brugger; alban millonig; A Fogdell-Hahn; D Rudzki; J Hillert; Thomas Berger; Markus Reindl; Florian Deisenhammer
Comparative study of four different assays for the detection of binding antibodies against interferon-beta.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(6):830-6.
2008: Julia Wanschitz; Rainer Ehling; Wolfgang N Löscher; Betinna Künz; Florian Deisenhammer; Jens Kuhle; Herbert Budka; Markus Reindl; Thomas Berger
Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.
Journal of neurology 2008;255(6):917-24.
2008: Anelia Dietmann; Raimund Helbok; Peter Lackner; Saadou Issifou; Bertrand Lell; Pierre-Blaise Matsiegui; Markus Reindl; Erich Schmutzhard; Song Le
Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity.
The Journal of infectious diseases 2008;197(11):1614-20.
2008: Anelia Dietmann; Peter Lackner; Raimund Helbok; Katharina Spora; Saadou Issifou; Bertrand Lell; Markus Reindl; Song Le; Erich Schmutzhard
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria.
Malaria journal 2008;7():253.
2008: Bettina Kuenz; Andreas Lutterotti; Rainer Ehling; Claudia Gneiss; Monika Haemmerle; Carolyn Rainer; Florian Deisenhammer; Michael Schocke; Thomas Berger; Markus Reindl
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis.
PloS one 2008;3(7):e2559.
2008: Markus Hutterer; Pjotr Knyazev; Ariane Abate; Markus Reschke; Hans Maier; Nadia Stefanova; Tatjana Knyazeva; Verena Barbieri; Markus Reindl; Armin Muigg; Herwig Kostron; Günther Stockhammer; Axel Ullrich
Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):130-8.
2007: Nadia Stefanova; Markus Reindl; Manuela Neumann; Philipp J Kahle; Werner Poewe; Gregor Wenning
Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2007;22(15):2196-203.
2007: Bettina Kuenz; Thomas Berger; Florian Deisenhammer; Markus Reindl
Diagnostic biomarkers in multiple sclerosis.
Expert opinion on medical diagnostics 2007;1(2):225-33.
2007: Thomas Berger; Markus Reindl
Multiple sclerosis: disease biomarkers as indicated by pathophysiology.
Journal of the neurological sciences 2007;259(1-2):21-6.
2007: Martin Köllensperger; Nadia Stefanova; Markus Reindl; Werner Poewe; Gregor Wenning
Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2007;22(3):353-8.
2007: Jens Kuhle; Raija L P Lindberg; Axel Regeniter; Matthias Mehling; Francine Hoffmann; Markus Reindl; Thomas Berger; Ernst-Wilhelm Radue; David Leppert; Ludwig Kappos
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.
Journal of neurology 2007;254(2):160-8.
2007: Qingzhong Xiao; Stefan Kiechl; Seema Patel; Friedrich Oberhollenzer; Siegfried Weger; Andreas J Mayr; Bernhard Metzler; Markus Reindl; Yanhua Hu; Johann Willeit; Qingbo Xu
Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis--results from a large population-based study.
PloS one 2007;2(10):e975.
2007: Andreas Lutterotti; Thomas Berger; Markus Reindl
Biological markers for multiple sclerosis.
Current medicinal chemistry 2007;14(18):1956-65.
2006: Claudia Gneiss; P Tripp; F Reichartseder; Robert Egg; Rainer Ehling; Andreas Lutterotti; Michael Khalil; Bettina Kuenz; Irmgard Mayringer; Markus Reindl; Thomas Berger; Florian Deisenhammer
Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(6):731-7.
2006: Andreas Lutterotti; Bettina Kuenz; Viktoria Gredler; Michael Khalil; Rainer Ehling; Claudia Gneiss; Robert Egg; Florian Deisenhammer; Thomas Berger; Markus Reindl
Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Journal of neuroimmunology 2006;181(1-2):145-9.
2006: Markus Reindl; Michael Khalil; Thomas Berger
Antibodies as biological markers for pathophysiological processes in MS.
Journal of neuroimmunology 2006;180(1-2):50-62.
2006: S Rauer; B Euler; Markus Reindl; Th Berger
Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.
Journal of neurology, neurosurgery, and psychiatry 2006;77(6):739-42.
2006: Claudia Gneiss; P Tripp; Rainer Ehling; Michael Khalil; Andreas Lutterotti; Robert Egg; Irmgard Mayringer; B Künz; Thomas Berger; Markus Reindl; Florian Deisenhammer
Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
Journal of neuroimmunology 2006;174(1-2):174-9.
2006: Michael Khalil; Markus Reindl; Andreas Lutterotti; Bettina Kuenz; Rainer Ehling; Claudia Gneiss; Peter Lackner; Florian Deisenhammer; Thomas Berger
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
Journal of neuroimmunology 2006;174(1-2):147-56.
2006: Thomas Berger; Markus Reindl
Biomarkers in multiple sclerosis: role of antibodies.
Disease markers 2006;22(4):207-12.
2005: Bettina Kuenz; Andreas Lutterotti; Michael Khalil; Rainer Ehling; Claudia Gneiss; Florian Deisenhammer; Markus Reindl; Thomas Berger
Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
Journal of neuroimmunology 2005;167(1-2):143-9.
2005: Nadia Stefanova; François Tison; Markus Reindl; Werner Poewe; Gregor Wenning
Animal models of multiple system atrophy.
Trends in neurosciences 2005;28(9):501-6.
2005: Nadia Stefanova; Markus Reindl; Werner Poewe; Gregor Wenning
In vitro models of multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2005;20 Suppl 12():S53-6.
2005: Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor Wenning
Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.
The American journal of pathology 2005;166(3):869-76.
2004: Rainer Ehling; Andreas Lutterotti; Julia Wanschitz; Michael Khalil; Claudia Gneiss; Florian Deisenhammer; Markus Reindl; Thomas Berger
Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(6):601-6.
2004: Claudia Gneiss; Markus Reindl; Andreas Lutterotti; Rainer Ehling; Robert Egg; Michael Khalil; Thomas Berger; Florian Deisenhammer
Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(5):507-10.
2004: Karma V Moser; Markus Reindl; Ingolf E Blasig; Christian Humpel
Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation.
Brain research 2004;1017(1-2):53-60.
2004: Claudia Gneiss; Markus Reindl; Thomas Berger; Andreas Lutterotti; Rainer Ehling; Robert Egg; Florian Deisenhammer
Epitope specificity of neutralizing antibodies against IFN-beta.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2004;24(5):283-90.
2004: Rainer Ehling; Christoph Gassner; Andreas Lutterotti; Siegrid Strasser-Fuchs; H Kollegger; W Kristoferitsch; Markus Reindl; Thomas Berger
Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosis.
Tissue antigens 2004;63(1):28-33.
2003: Markus Reindl; Sabrina Khantane; Rainer Ehling; Kathrin Schanda; Andreas Lutterotti; Claudia Brinkhoff; Thomas Oertle; Martin E Schwab; Florian Deisenhammer; Thomas Berger; Christine E Bandtlow
Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders.
Journal of neuroimmunology 2003;145(1-2):139-47.
2003: Nadia Stefanova; Kathrin Schanda; Lars Klimaschewski; Werner Poewe; Gregor Wenning; Markus Reindl
Tumor necrosis factor-alpha-induced cell death in U373 cells overexpressing alpha-synuclein.
Journal of neuroscience research 2003;73(3):334-40.
2003: Nadia Stefanova; Zoe Puschban; Pierre-Olivier Fernagut; Emmanuel Brouillet; François Tison; Markus Reindl; Kurt A Jellinger; Werner Poewe; Gregor Wenning
Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy).
Acta neuropathologica 2003;106(2):157-66.
2003: Thomas Berger; Paul Rubner; Franz Schautzer; Robert Egg; Hanno Ulmer; Irmgard Mayringer; Erika Dilitz; Florian Deisenhammer; Markus Reindl
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.
The New England journal of medicine 2003;349(2):139-45.
2003: Hans Lassmann; Markus Reindl; Helmut Rauschka; Johannes Berger; Fahmy Aboul-Enein; Thomas Berger; Andreas Zurbriggen; Andreas Lutterotti; Wolfgang Brück; Jörg R Weber; Robert Ullrich; Manfred Schmidbauer; Kurt A Jellinger; Marc Vandevelde
A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions.
Brain : a journal of neurology 2003;126(Pt 6):1347-57.
2003: Kayvon Salimi; Karma V Moser; Josef Marksteiner; Markus Reindl; Christian Humpel
GDNF and TGF-beta1 promote cell survival in serum-free cultures of primary rat microglia.
Cell and tissue research 2003;312(1):135-9.
2003: M Kob; J Harvey; Franz Schautzer; S Kascha; D Bibl; Robert Egg; Markus Reindl; Thomas Berger; Florian Deisenhammer
A novel and rapid assay for the detection of neutralizing antibodies against interferon-beta.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(1):32-5.
2003: Markus Reindl; Andreas Lutterotti; J Ingram; Kathrin Schanda; Christoph Gassner; Florian Deisenhammer; Thomas Berger; E Lorenz
Mutations in the gene for toll-like receptor 4 and multiple sclerosis.
Tissue antigens 2003;61(1):85-8.
2002: Andreas Lutterotti; Markus Reindl; Christoph Gassner; Katharina Poustka; Kathrin Schanda; Florian Deisenhammer; Thomas Berger
Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.
Journal of neuroimmunology 2002;131(1-2):201-7.
2002: Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz
Toll-like receptor 4 polymorphisms and atherogenesis.
The New England journal of medicine 2002;347(3):185-92.
2002: Kayvon Salimi; Karma Moser; Birgit Zassler; Markus Reindl; Norbert Embacher; Christine Schermer; Carla Weis; Josef Marksteiner; Makoto Sawada; Christian Humpel
Glial cell line-derived neurotrophic factor enhances survival of GM-CSF dependent rat GMIR1-microglial cells.
Neuroscience research 2002;43(3):221-9.
2002: Nadia Stefanova; M Emgård; Lars Klimaschewski; Gregor Wenning; Markus Reindl
Ultrastructure of alpha-synuclein-positive aggregations in U373 astrocytoma and rat primary glial cells.
Neuroscience letters 2002;323(1):37-40.
2001: Robert Egg; Markus Reindl; Florian Deisenhammer; Christopher Linington; Thomas Berger
Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(5):285-9.
2001: Markus Reindl; G Knipping; I Wicher; Erika Dilitz; Robert Egg; Florian Deisenhammer; Thomas Berger
Increased intrathecal production of apolipoprotein D in multiple sclerosis.
Journal of neuroimmunology 2001;119(2):327-32.
2001: Franz Fazekas; Siegrid Strasser-Fuchs; H Kollegger; Thomas Berger; W Kristoferitsch; Helena Schmidt; Christian Enzinger; Mark Schiefermeier; C Schwarz; B Kornek; Markus Reindl; K Huber; R Grass; Gernot Wimmer; Karl Vass; K H Pfeiffer; Hans-Peter Hartung; Reinhold Schmidt
Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.
Neurology 2001;57(5):853-7.
2001: Nadia Stefanova; Lars Klimaschewski; Werner Poewe; Gregor Wenning; Markus Reindl
Glial cell death induced by overexpression of alpha-synuclein.
Journal of neuroscience research 2001;65(5):432-8.
2001: Irmgard Mayringer; Markus Reindl; Bettina Pfausler; W Berger; Thomas Berger; Erich Schmutzhard
Are cytokines and adhesion molecules useful parameters to differentiate bacterial from fungal ventriculitis?
Intensive care medicine 2001;27(6):1097.
2001: Florian Deisenhammer; Markus Reindl; Thomas Berger
Immunoglobulin subclasses in patients with neutralizing and nonneutralizing antibodies against IFN-beta1b.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2001;21(3):167-71.
2001: C G Haase; J Guggenmos; U Brehm; M Andersson; Tomas Olsson; Markus Reindl; Jana-Marie Schneidewind; UK Zettl; F Heidenreich; Thomas Berger; Hartmut Wekerle; Reinhard Hohlfeld; Christopher Linington
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.
Journal of neuroimmunology 2001;114(1-2):220-5.
2000: Florian Deisenhammer; Irmgard Mayringer; J Harvey; Erika Dilitz; T Gasse; D Stadlbauer; Markus Reindl; Thomas Berger
A comparative study of the relative bioavailability of different interferon beta preparations.
Neurology 2000;54(11):2055-60.
2000: Ronny Beer; Gerhard Franz; M Schöpf; Markus Reindl; B Zelger; Erich Schmutzhard; Werner Poewe; Andreas Kampfl
Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2000;20(4):669-77.
2000: Irmgard Mayringer; Markus Reindl; Thomas Berger
A critical comparison of frequently used methods for the analysis of tumor necrosis factor-alpha expression by human immune cells.
Journal of immunological methods 2000;235(1-2):33-40.
2000: Thomas Berger; Markus Reindl
Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis.
Journal of neural transmission. Supplementum 2000;(60):351-60.
1999: Markus Reindl; Christopher Linington; U Brehm; Robert Egg; Erika Dilitz; Florian Deisenhammer; Werner Poewe; Thomas Berger
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Brain : a journal of neurology 1999;122 ( Pt 11)():2047-56.
1999: Gerhard Franz; Markus Reindl; S C Patel; Ronny Beer; I Unterrichter; Thomas Berger; Erich Schmutzhard; Werner Poewe; Andreas Kampfl
Increased expression of apolipoprotein D following experimental traumatic brain injury.
Journal of neurochemistry 1999;73(4):1615-25.
1999: Florian Deisenhammer; Markus Reindl; J Harvey; T Gasse; Erika Dilitz; Thomas Berger
Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies.
Neurology 1999;52(6):1239-43.